Delivery Order 36F79720D0075-36C26124N0656
Award Date
5/15/24
Potential Completion Date
5/30/24
Potential Value
$2.4K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Vifor (International) AG
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94063, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award valued at $2,651.76 to Vifor (International) AG, a foreign-owned, for-profit pharmaceutical manufacturer, for the delivery of KORSUVA 50 MG. The contract was awarded by the U.S. Department of Veterans Affairs (VA) through the VA National Acquisition Center and is structured as a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has an ultimate completion date of February 28, 2025 and uses a Firm Fixed Price...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $1,212.73 firm-fixed price delivery order to Vifor (International) AG, a global biotechnology company, to supply DIFELIKEFALIN 50MCG/ML INJ,SOLN VIAL,1.3ML (KORSUVA) pharmaceuticals to VA facilities in Redwood City, CA. This order was placed under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. Vifor has also received previous awards from the VA, including a $23.8 million Blanket...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed price delivery order to Vifor (International) AG, a global biotechnology company, to supply the medication KRYSTEXXA 8MG. The $3,678.19 order is placed against Vifor's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which allows the VA to streamline acquisition of critical pharmaceuticals to support healthcare for veterans. No set-aside was used for this delivery order. Vifor...
This is a federal contract award by the Department of Veterans Affairs (VA) to Vifor (International) AG, a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of KORSUVA 50 MG, a medication for pruritus (itching). The contract, valued at $1,365.88, is a delivery order issued under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. It has an ultimate completion date of February 28, 2025. The contract is a firm fixed-price arrangement and does not...
Vifor (International) AG was awarded a $3,638.19 delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to supply pharmaceuticals under the Pharmaceuticals and Drugs Federal Supply Schedule. The order has a completion date of April 30, 2024 and was awarded on January 31, 2024 without a set-aside designation. Vifor will provide KORSUVA, a pharmaceutical used to treat medical conditions, to VA facilities located in La Vergne,...
This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Vifor (International) AG, a global pharmaceutical company, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The $29,105.52 order is for the delivery of the drug Korsuva to VA facilities in Tennessee by April 30, 2025. Vifor has previously received other delivery orders and a $23.8 million Blanket Purchase Agreement from the VA to supply pharmaceuticals such as Mircera to...
Vifor (International) AG has been awarded a $1,212.73 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. This firm fixed price order, to be completed by February 29, 2024, is for pharmaceutical products to support the VA's healthcare programs serving veterans in the La Vergne, Tennessee area. No set-aside designation was applied to this order. Vifor...
This federal contract award is for the delivery of the pharmaceutical product KRYSTEXXA 8MG to the Department of Veterans Affairs (VA) Veterans Health Administration. The $2,425.46 firm-fixed price delivery order was awarded to the prime contractor Vifor (International) AG, a global biotechnology company that provides pharmaceuticals and drugs through its Federal Supply Schedule contract. The contract is associated with the VA's Pharmaceuticals and Drugs (FSS-61-IB) Schedule, and the delivery...
The U.S. Department of Veterans Affairs (VA) awarded a $76,896.72 firm fixed-price delivery order to Horizon Therapeutics USA, Inc. for the specialty pharmaceutical KRYSTEXXA 8MG. The award is part of Horizon's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) and is placed by the VA's Veterans Integrated Service Network (VISN) 5. This delivery order supports the VA's mission to provide comprehensive healthcare services to the veteran population, as KRYSTEXXA is...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The contract, valued at $41,636,277.00, is for the delivery of pharmaceutical and medical supplies, with no set-aside designation. The contract is structured as a firm fixed-price, delivery order arrangement to support medical facilities worldwide, particularly for the Department of Defense...